Evaluation of the Efficacy and Safety of Topical Procyanidin B2 and Placebo in the Treatment of Androgenetic Alopecia in Men: A Randomized, Double-Blind, Placebo-Controlled Study

    January 2022 in “ Turk Dermatoloji Dergisi
    Yıldıray Yeniay, Ercan Arca
    Image of study
    TLDR Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.
    This document summarizes a study that evaluated the effectiveness and safety of topical procyanidin B2 in treating androgenetic alopecia (AGA) in men. The study included 40 male patients with AGA type II-IV who were randomly assigned to receive either topical procyanidin B2 or a placebo for 16 weeks. The results showed that the group treated with procyanidin B2 had a significant increase in total hair count and anagen hair count compared to the placebo group. The study concluded that topical procyanidin B2 is an effective and safe treatment option for AGA patients.
    View this study on tjdonline.org →

    Cited in this study

    27 / NoResults

    Related

    9 / NoResults